Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(33.3%)
Phase 3
1(33.3%)
N/A
1(33.3%)
3Total
Phase 4(1)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04897269Phase 3Unknown

Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day

Role: lead

NCT04531644Not ApplicableUnknown

Double Stimulation in Women With Low Prognosis in ART

Role: lead

NCT04923217Completed

Quality of Life and Sexual Function in Vaginal Aplasia Patients After Davydov Procedure

Role: collaborator

NCT03922594Terminated

Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia

Role: collaborator

NCT00547170Phase 4Completed

Doxycycline Prophylaxis at Vacuum Aspiration Trial

Role: collaborator

All 5 trials loaded